Amicogen Inc
KOSDAQ:092040
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rovio Entertainment Oyj
OMXH:ROVIO
|
FI |
Amicogen Inc
Long-Term Debt
Amicogen Inc
Long-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Amicogen Inc
KOSDAQ:092040
|
Long-Term Debt
₩54.2B
|
CAGR 3-Years
2%
|
CAGR 5-Years
49%
|
CAGR 10-Years
39%
|
|
|
Celltrion Inc
KRX:068270
|
Long-Term Debt
₩412.3B
|
CAGR 3-Years
39%
|
CAGR 5-Years
15%
|
CAGR 10-Years
4%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Long-Term Debt
₩409.7m
|
CAGR 3-Years
-70%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Long-Term Debt
₩4.2B
|
CAGR 3-Years
75%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Long-Term Debt
₩189.1m
|
CAGR 3-Years
-83%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Long-Term Debt
₩6.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amicogen Inc
Glance View
Amicogen, Inc. engages in the development and sale of enzyme products and functional food materials. The company is headquartered in Jinju, Gyeongsangnam-Do. The company went IPO on 2013-09-12. The Company’s products consist of special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins. The firm distributes its products within domestic market and to overseas markets, including China, Japan, the United Sates, Germany and Thailand.
See Also
What is Amicogen Inc's Long-Term Debt?
Long-Term Debt
54.2B
KRW
Based on the financial report for Dec 31, 2025, Amicogen Inc's Long-Term Debt amounts to 54.2B KRW.
What is Amicogen Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
39%
Over the last year, the Long-Term Debt growth was -22%. The average annual Long-Term Debt growth rates for Amicogen Inc have been 2% over the past three years , 49% over the past five years , and 39% over the past ten years .
